Skip to main content
Top

International Journal of Hematology

Issue 4/2017

Content (17 Articles)

Images in Hematology

Extradural plasmacytoma with central nervous system involvement in newly diagnosed multiple myeloma

Satoshi Kaito, Hideharu Muto, Shunta Takebayashi, Yutaka Otsubo, Shuichi Miyawaki, Kazuteru Ohashi

Rapid Communication

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation

Mats Remberger, Johan Törlen, Ibrahim El Serafi, Karin Garming-Legert, Andreas Björklund, Per Ljungman, Mikael Sundin, Moustapha Hassan, Jonas Mattsson

Original Article

TRAIL in CD8+ T cells from patients with severe aplastic anemia

Chunyan Liu, Mengying Zheng, Tian Zhang, Rong Fu, Huaquan Wang, Ting Wang, Weiwei Qi, Zonghong Shao

Original Article

Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis

Yunsuk Choi, Jae-Cheol Jo, Hee-jeong Jeon, Dong Wook Kim, Myung Hee Chang, Hawk Kim

Original Article

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

Tomás José González-López, Fernando Fernández-Fuertes, José Angel Hernández-Rivas, Blanca Sánchez-González, Violeta Martínez-Robles, María Teresa Alvarez-Román, Gloria Pérez-Rus, Cristina Pascual, Silvia Bernat, Esther Arrieta-Cerdán, Carlos Aguilar, Abelardo Bárez, María Jesús Peñarrubia, Pavel Olivera, Angeles Fernández-Rodríguez, Erik de Cabo, Luis Javier García-Frade, José Ramón González-Porras

Original Article

Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms

Jean-Christophe Ianotto, Marie-Anne Couturier, Hubert Galinat, Dominique Mottier, Christian Berthou, Gaëlle Guillerm, Eric Lippert, Aurélien Delluc

Original Article

Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia–lymphoma in Japan: interim results of postmarketing all-case surveillance

Kenji Ishitsuka, Satoshi Yurimoto, Kouichi Kawamura, Yukie Tsuji, Manabu Iwabuchi, Takeshi Takahashi, Kensei Tobinai

Original Article

Efficacy of prophylactic irradiation to the contralateral testis for patients with advanced-stage primary testicular lymphoma: an analysis of outcomes at a single institution

Ryouji Tokiya, Eisaku Yoden, Kei Konishi, Nobuhiko Kamitani, Junichi Hiratsuka, Risa Koresawa, Tadashi Hirose, Fuminori Sano, Hirotoshi Tokunaga, Toshinori Kondo, Hideho Wada, Takashi Sugihara

Original Article

Safety and efficacy of daratumumab in Japanese patients with relapsed or refractory multiple myeloma: a multicenter, phase 1, dose-escalation study

Shinsuke Iida, Kenshi Suzuki, Shigeru Kusumoto, Masaki Ri, Nobuhiro Tsukada, Yu Abe, Masayuki Aoki, Mitsuo Inagaki

Original Article

FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation

Shanhao Tang, Hongjie Shen, Xinliang Mao, Haiping Dai, Xiaming Zhu, Shengli Xue, Zixuan Ding, Jing Lu, Depei Wu, Xiaowen Tang

Original Article

Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma

Masaki Ri, Kosei Matsue, Kazutaka Sunami, Chihiro Shimazaki, Akio Hayashi, Yoshinori Sunaga, Toru Sasaki, Kenshi Suzuki

Original Article

Costs of hematopoietic stem cell transplantation in a developing country

Monica M. Rivera-Franco, Eucario Leon-Rodriguez, Haydee L. Castro-Saldaña

Case Report

Three cases of relapsed/refractory multiple myeloma under hemodialysis treated with panobinostat/bortezomib/dexamethasone (FVD)

Yasunobu Sekiguchi, Haruko Takizawa, Tadaaki Inano, Yasutaka Fukuda, Mutsumi Wakabayashi, Keiji Sugimoto, Shigeki Tomita, Hiroshi Izumi, Noriko Nakamura, Tomohiro Sawada, Yasunori Ohta, Norio Komatsu, Masaaki Noguchi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine